2026 Training Seminars (In-Person Only)

*Separate registration is required.

The Training Seminars Will Be Offered In-Person Only
To ensure a cohesive and focused learning environment, moving between conference sessions and the training seminars are not allowed.





Training Seminars

Monday, October 19, 2026 9:00 AM – 5:00 PM

TS2A: Biostatistics for Beginners

This training course is tailored for professionals who are not statisticians but need to apply statistical concepts for bioassay analysis. It serves as an introduction to fundamental statistical principles and practices, equipping participants with the knowledge to analyze data, interpret results, and make informed decisions based on statistical evidence. Through interactive examples and case studies, participants will learn key concepts like hypothesis testing, sample size determination, and experimental design, among others. Whether you're involved in assay development, assay optimization, quality control, or research and development, this course will empower you to effectively use statistical tools to enhance your work and make data-driven decisions with confidence.
Biostatistics for Beginners
Steven Walfish, Principal CMC Statistician, Iovance Biotherapeutics

Topics to be covered: 

  • Statistics: definition and its application to assay development 
  • The arithmetic mean, the standard deviation, and how to prove differences 
  • Assay intended use, hypothesis testing, and evaluating fitness-for-purpose 
  • Inferential statistics: terminology and symbols explained 
  • Standard error of the mean, t values, and p values 
  • Reported mean values, margin of error, and confidence interval of a mean 
  • Statistical Significance: difference vs. equivalence testing
  • Type I and Type II errors and statistical power
  • Dose response curve-model selection, system and sample suitability evaluation
  • Log transformation of response readouts and relative potency values
  • Calculating relative potency values: parallel line vs. 4 PL
  • Quality-by-Design (QbD): assays as processes to be optimized and evaluated against target performance requirements
  • Overview of available guidance: FDA, USP, and ICH documents


Participants will leave the course with:  

  • A strong foundation in statistical terminology and practices
  • The ability to design and evaluate experiments effectively
  • Practical insights into optimizing assays and improving quality
  • Confidence in applying statistical tools to real-world scenarios.

INSTRUCTOR BIOGRAPHY:

Photo of Steven Walfish, Principal CMC Statistician, Iovance Biotherapeutics
Steven Walfish, Principal CMC Statistician, Iovance Biotherapeutics
Mr. Walfish is Principal Science & Standards Liaison at United States Pharmacopeia (USP) responsible for the Statistics Expert Committee. Prior to this role Mr. Walfish was Principal Statistician at Becton Dickinson in Franklin Lakes, NJ responsible for supporting continuous improvement efforts and process development for worldwide operations. Mr. Walfish has held roles at GE Healthcare, Human Genome Sciences and Chiron. Steven was President of Statistical Outsourcing Services, a consulting company that provides statistical analysis and training to the FDA regulated industries. Mr. Walfish brings over 30 years of industrial expertise in the development and application of statistical methods for solving complex business issues. Steven has experience applying statistical methods to analytical method verification and validation and stability analysis. Mr. Walfish holds a Bachelors of Arts in Statistics from the University of Buffalo, Masters of Science in Statistics from Rutgers University and an Executive MBA from Boston University.

Tuesday, October 20, 2026 8:30 AM – 5:30 PM | Wednesday, October 21, 2026 8:00 AM – 12:00 PM

TS2B: Statistical Methods for Bioassay Development and Analysis

This course will focus on factors to be considered in the design, development, and validation of bioassays. The course introduces terminology and important statistical tools and best practices. Examples and case studies will be provided to help solidify understanding on the topics of design and development, robustness, validation, and post-validation. Relevant pharmacopeial and EUA regulations will be highlighted.
Statistical Methods for Bioassay Development and Analysis
Steven Walfish, Principal CMC Statistician, Iovance Biotherapeutics

Topics to be covered:

  • Introduction to Bioassays
  • Guidance Documents on Bioassays
  • Design & Development 
  • Robustness 
  • Validation & Post Validation
  • Statistical Analysis Models
  • Examples/Case Studies​

Who should attend? 

  • Bioassay Development Scientists
  • QA/QC Personnel
  • Stability Scientist
  • Statisticians
  • CMC Scientists
  • Assay Development Scientists​

Key takeaways: 

  • Recognize applicable terminology
  • Explain concepts of relative potency
  • Understand the bioassay life-cycle
  • Recognize bioassay best practices
  • Explain bioassay design and development: fitness for use/potential challenges, screening and optimization, data and assumptions, variance heterogeneity, goodness for fit, and measurement of uncertainty, normality, transformation and weighting, validity/assay/system/sample suitable criteria, and acceptance criteria
  • Understand robustness (experimental design concepts)
  • Explain bioassay validation and post-validation: Identifying and measuring significant sources of error, experimental design, and acceptance criteria and  the statistical considerations involved​

INSTRUCTOR BIOGRAPHY:

Photo of Steven Walfish, Principal CMC Statistician, Iovance Biotherapeutics
Steven Walfish, Principal CMC Statistician, Iovance Biotherapeutics
Mr. Walfish is Principal Science & Standards Liaison at United States Pharmacopeia (USP) responsible for the Statistics Expert Committee. Prior to this role Mr. Walfish was Principal Statistician at Becton Dickinson in Franklin Lakes, NJ responsible for supporting continuous improvement efforts and process development for worldwide operations. Mr. Walfish has held roles at GE Healthcare, Human Genome Sciences and Chiron. Steven was President of Statistical Outsourcing Services, a consulting company that provides statistical analysis and training to the FDA regulated industries. Mr. Walfish brings over 30 years of industrial expertise in the development and application of statistical methods for solving complex business issues. Steven has experience applying statistical methods to analytical method verification and validation and stability analysis. Mr. Walfish holds a Bachelors of Arts in Statistics from the University of Buffalo, Masters of Science in Statistics from Rutgers University and an Executive MBA from Boston University.

Register

CONFERENCE PROGRAMS

Symposium: Immunology for Biotherapeutics